Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct-acting antivirals

Authors:

Abstract
No abstract available
Funding Information
  • Merck Sharp and Dohme United Kingdom
  • AbbVie
  • Gilead Sciences

This publication has 38 references indexed in Scilit: